Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Show more
3963 Maple Avenue, Dallas, TX, 75219, United States
Market Cap
54.8M
52 Wk Range
$5.67 - $42.79
Previous Close
$8.08
Open
$8.15
Volume
16,178
Day Range
$7.95 - $8.15
Enterprise Value
65.82M
Cash
74.57M
Avg Qtr Burn
-1.337M
Insider Ownership
6.29%
Institutional Own.
62.20%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
ITIL-306 Details Cancer, Non-small cell lung carcinoma, Ovarian cancer, Renal cell carcinoma | Failed Discontinued | |
ITIL-168 Details Cancer, Melanoma | Failed Discontinued | |
AXN-2510 (formerly SYN-2510) /IMM2510 Details Relapsed/Refractory Solid Tumors | Failed Discontinued | |
AXN-2510/IMM2510 + chemotherapy Details Non-small cell lung carcinoma (NSCLC) | Failed Discontinued |
